MICHAEL SCHIMAN: Open Payments
NPI 1639657729 · SAINT JOSEPH, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$501 in 36 payments from 11 companies in 2025. Trend: 2023 $222 · 2024 $393 · 2025 $501
Food & beverage: $501
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $235 |
| Genentech USA, Inc. | 2 | $48 |
| Biogen, Inc. | 2 | $39 |
| TG Therapeutics, Inc. | 1 | $36 |
| Janssen Biotech, Inc. | 1 | $29 |
| PFIZER INC. | 1 | $24 |
| Cycle Pharmaceuticals Inc | 1 | $21 |
| EMD Serono, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
Products named: QULIPTA, BOTOX, BRIUMVI, Enspryng, PANZYGA, UBRELVY, TYSABRI, Ocrevus Zunovo.
Industry payments across MI — which companies pay providers there.
